Literature DB >> 21938401

The inositol Inpp5k 5-phosphatase affects osmoregulation through the vasopressin-aquaporin 2 pathway in the collecting system.

Eileen Pernot1, Sara Terryn, Siew Chiat Cheong, Nicolas Markadieu, Sylvie Janas, Marianne Blockmans, Monique Jacoby, Valérie Pouillon, Stéphanie Gayral, Bernard C Rossier, Renaud Beauwens, Christophe Erneux, Olivier Devuyst, Stéphane Schurmans.   

Abstract

Inositol Inpp5k (or Pps, SKIP) is a member of the inositol polyphosphate 5-phosphatases family with a poorly characterized function in vivo. In this study, we explored the function of this inositol 5-phosphatase in mice and cells overexpressing the 42-kDa mouse Inpp5k protein. Inpp5k transgenic mice present defects in water metabolism characterized by a reduced plasma osmolality at baseline, a delayed urinary water excretion following a water load, and an increased acute response to vasopressin. These defects are associated with the expression of the Inpp5k transgene in renal collecting ducts and with alterations in the arginine vasopressin/aquaporin-2 signalling pathway in this tubular segment. Analysis in a mouse collecting duct mCCD cell line revealed that Inpp5k overexpression leads to increased expression of the arginine vasopressin receptor type 2 and increased cAMP response to arginine vasopressin, providing a basis for increased aquaporin-2 expression and plasma membrane localization with increased osmotically induced water transport. Altogether, our results indicate that Inpp5k 5-phosphatase is important for the control of the arginine vasopressin/aquaporin-2 signalling pathway and water transport in kidney collecting ducts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21938401     DOI: 10.1007/s00424-011-1028-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  39 in total

1.  Identification and characterization of a novel inositol polyphosphate 5-phosphatase.

Authors:  T Ijuin; Y Mochizuki; K Fukami; M Funaki; T Asano; T Takenawa
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

Review 2.  An emerging role for PtdIns(4,5)P2-mediated signalling in human disease.

Authors:  Jonathan R Halstead; Kees Jalink; Nullin Divecha
Journal:  Trends Pharmacol Sci       Date:  2005-10-25       Impact factor: 14.819

Review 3.  Membrane recognition by phospholipid-binding domains.

Authors:  Mark A Lemmon
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

4.  Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.

Authors:  T Wada; T Sasaoka; M Funaki; H Hori; S Murakami; M Ishiki; T Haruta; T Asano; W Ogawa; H Ishihara; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.

Authors:  Mark W Sleeman; Katherine E Wortley; Ka-Man V Lai; Lori C Gowen; Jennifer Kintner; William O Kline; Karen Garcia; Trevor N Stitt; George D Yancopoulos; Stanley J Wiegand; David J Glass
Journal:  Nat Med       Date:  2005-01-16       Impact factor: 53.440

6.  PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.

Authors:  Ali K Ahrabi; Sara Terryn; Giovanna Valenti; Nathalie Caron; Claudine Serradeil-Le Gal; Danielle Raufaste; Soren Nielsen; Shigeo Horie; Jean-Marc Verbavatz; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

7.  Complex functions of phosphatidylinositol 4,5-bisphosphate in regulation of TRPC5 cation channels.

Authors:  Mohamed Trebak; Loic Lemonnier; Wayne I DeHaven; Barbara J Wedel; Gary S Bird; James W Putney
Journal:  Pflugers Arch       Date:  2008-07-30       Impact factor: 3.657

Review 8.  The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.

Authors:  Lisa M Ooms; Kristy A Horan; Parvin Rahman; Gillian Seaton; Rajendra Gurung; Dharini S Kethesparan; Christina A Mitchell
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

9.  The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man.

Authors:  Evelyne Marion; Pamela Jane Kaisaki; Valérie Pouillon; Cyril Gueydan; Jonathan C Levy; André Bodson; Georges Krzentowski; Jean-Claude Daubresse; Jean Mockel; Jens Behrends; Geneviève Servais; Claude Szpirer; Véronique Kruys; Dominique Gauguier; Stéphane Schurmans
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

Review 10.  Mutations in phosphoinositide metabolizing enzymes and human disease.

Authors:  Heather J McCrea; Pietro De Camilli
Journal:  Physiology (Bethesda)       Date:  2009-02
View more
  2 in total

1.  TRPV4 is associated with central rather than nephrogenic osmoregulation.

Authors:  Sylvie Janas; François Seghers; Olivier Schakman; Mohammad Alsady; Peter Deen; Joris Vriens; Fadel Tissir; Bernd Nilius; Johannes Loffing; Philippe Gailly; Olivier Devuyst
Journal:  Pflugers Arch       Date:  2016-06-30       Impact factor: 3.657

2.  The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes.

Authors:  Cynthia J Curry; Jill A Rosenfeld; Erica Grant; Karen W Gripp; Carol Anderson; Arthur S Aylsworth; Taha Ben Saad; Victor V Chizhikov; Giedre Dybose; Christina Fagerberg; Michelle Falco; Christina Fels; Marco Fichera; Jesper Graakjaer; Donatella Greco; Jennifer Hair; Elizabeth Hopkins; Marlene Huggins; Roger Ladda; Chumei Li; John Moeschler; Malgorzata J M Nowaczyk; Jillian R Ozmore; Santina Reitano; Corrado Romano; Laura Roos; Rhonda E Schnur; Susan Sell; Pim Suwannarat; Dea Svaneby; Marta Szybowska; Mark Tarnopolsky; Raymond Tervo; Anne Chun-Hui Tsai; Megan Tucker; Stephanie Vallee; Ferrin C Wheeler; Dina J Zand; A James Barkovich; Swaroop Aradhya; Lisa G Shaffer; William B Dobyns
Journal:  Am J Med Genet A       Date:  2013-06-27       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.